Skip to main content

Advertisement

SpringerLink
Log in

A History of Pituitary Pathology

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

The history of pituitary pathology is a long one that dates back to biblical times, but the last 25 years have represented an era of “coming of age.” The role of the pituitary in health and disease was the subject of many studies over the last century. With the development of electron microscopy, immunoassays, and immunohistochemistry, the functional alterations associated with pituitary disease have been clarified. The additional information provided by molecular genetic studies has allowed progress in understanding the pathogenesis of pituitary disorders. Nevertheless, many questions remain to be answered. For example, pathologists cannot morphologically distinguish locally aggressive adenomas from carcinomas when tumor is confined to the sella. Sadly, basal cell carcinoma, the most common carcinoma of skin, usually causes less morbidity than pituitary adenomas, which occur in almost 20 % of the general population, can cause significant illness and even death, and yet are still classified as benign. The opportunity to increase awareness of the impact of these common lesions on quality of life is the current challenge for physicians and patients. We anticipate that ongoing multidisciplinary approaches to pituitary disease research will offer new insights into diseases arising from this fascinating organ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Descartes R. Des Passions de l’Ame. Amsterdam: 1649.

  2. Zander R. Ueber functionelle und genetische Beziehungen der Nebennieren zu anderen Organen, speciell zum Grosshirn. Beitr Pathol Anat 1890; 7:439–534.

    Google Scholar 

  3. Bernard C. Physiologie; chiens rendus diabétiques. C R Soc Biol (Paris) 1849; 1:60.

    Google Scholar 

  4. Marie P. Sur deux cas d’acromégalie. Hypertrophie singulière non congénitale des extremités supérieures, inférieures et céphaliques. Rev Méd 1886; 6:297–233.

    Google Scholar 

  5. Minkowski O. Ueber einen Fall von Akromegalie. Berl Klin Wochenschr 1887; 24:371–374.

    Google Scholar 

  6. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 1932; 50:137–195.

    Google Scholar 

  7. Simmonds M. Uber Hypophysisschwund mit tödlichen Ausgang. Deutsch med Wchnschr 1914; xl:322.

  8. Simmonds M. Atrophie des Hypophysisvorderlappens und hypophysäre Kachexie. Deutsch med Wchnschr 1918; xlix:852.

  9. Sheehan HL. Post-partum necrosis of the anterior pituitary. J Pathol Bacteriol 1937; 45:189–214.

    Article  CAS  Google Scholar 

  10. Harris GW. Neural control of the pituitary gland. Physiol Rev 1948; 28:139–179.

    PubMed  CAS  Google Scholar 

  11. Guillemin R, Rosenberg B. Humoral hypothalamic control of anterior pituitary: a study with combined tissue cultures. Endocrinology 1955; 57:599–607.

    Article  PubMed  CAS  Google Scholar 

  12. Burgus R, Dunn TF, Desiderio D, Guillemin R. Structure moléculaire du facteur hypothalamique TRH d’origine ovine: Mise en évidence par spectrométrie de masse. C R Acad Sci [III] 1969; 269:1870–1873.

    CAS  Google Scholar 

  13. Vale W, Grant G, Amoss M, Blackwell R, Guillemin R. Culture of enzymatically dispersed anterior pituitary cells: functional validation of a method. Endocrinology 1972; 91:562–572.

    Article  PubMed  CAS  Google Scholar 

  14. Brazeau P, Vale W, Burgus R et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973; 179:77–79.

    Article  PubMed  CAS  Google Scholar 

  15. Guillemin R, Vargo T, Rossier J et al. b-Endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 1977; 197:1367–1369.

    Article  PubMed  CAS  Google Scholar 

  16. Schally AV, Arimura A, Baba Y et al. Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun 1971; 43:393–399.

    Article  PubMed  CAS  Google Scholar 

  17. Guillemin R. Peptides in the brain: the new endocrinology of the neuron. Science 1978; 202:390–402.

    Article  PubMed  CAS  Google Scholar 

  18. Wilson WD, Ezrin C. Three types of chromophil cells of the adenohypophysis; demonstrated by a modification of the periodic acid-Schiff technique. Am J Pathol 1954; 30(5):891–899.

    PubMed Central  PubMed  CAS  Google Scholar 

  19. Ezrin C, Swanson HE, Humphrey JG, Dawson JW, Wilson WD. The delta cell of the human adenohypophysis: its response to acute and chronic illness. J Clin Endocrinol Metab 1958; 18(9):917–936.

    Article  PubMed  CAS  Google Scholar 

  20. Ezrin C, Swanson HE, Humphrey JG, Dawson JW, Hill FM. Beta and delta cells of the human adenohypophysis: their response to adrenocortical disorders. J Clin Endocrinol Metab 1959; 19(6): 621–631.

    Article  PubMed  CAS  Google Scholar 

  21. Ezrin C, Swanson HE, Humphrey JG, Dawson J, Hill FM. The cells of the human adenohypophysis in thyroid disorders. J Clin Endocrinol Metab 1959; 19:958–966.

    Article  PubMed  CAS  Google Scholar 

  22. Swanson HE, Ezrin C. The natural history of the delta cell of the human adenohypophysis: in childhood, adulthood and pregnancy. J Clin Endocrinol Metab 1960; 20:952–966.

    Article  PubMed  CAS  Google Scholar 

  23. Kovacs K, Horvath E. Tumors of the Pituitary Gland. Atlas of Tumor Pathology, Second Series, Fascicle 21. Washington, D.C.: Armed Forces Institute of Pathology, 1986.

    Google Scholar 

  24. Yamada S, Asa SL, Kovacs K, Muller P, Smyth HS. Analysis of hormone secretion by clinically nonfunctioning human pituitary adenomas using the reverse hemolytic plaque assay. J Clin Endocrinol Metab 1989; 68:73–80.

    Article  PubMed  CAS  Google Scholar 

  25. Asa SL. Tumors of the Pituitary Gland. Atlas of Tumor Pathology, Third Series, Fascicle 22. Washington, D.C., Armed Forces Institute of Pathology. 1988.

  26. Asa SL, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 1998; 19:798–827.

    PubMed  CAS  Google Scholar 

  27. Lee EB, Tihan T, Scheithauer BW, Zhang PJ, Gonatas NK. Thyroid transcription factor 1 expression in sellar tumors: a histogenetic marker? J Neuropathol Exp Neurol 2009; 68(5):482–488.

    Article  PubMed  CAS  Google Scholar 

  28. Mete O, Lopes MB, Asa SL. Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma. Am J Surg Pathol 2013; 37(11):1694–1699.

    Article  PubMed  Google Scholar 

  29. Kamil Z, Sinson S, Gucer H, Asa SL, Mete O. TTF-1 expressing sellar neoplasm with ependymal rosettes and oncocytic change: Mixed ependymal and oncocytic variant pituicytoma. Endocr Pathol 2013, in press.

  30. Asa SL. The role of hypothalamic hormones in the pathogenesis of pituitary adenomas. Pathol Res Pract 1991; 187:581–583.

    Article  PubMed  CAS  Google Scholar 

  31. Colao A, Di Sarno A, Cappabianca P, Di Somma C, Pivonello R, Lombardi G. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med 2003; 349(21):2023–2033.

    Article  PubMed  CAS  Google Scholar 

  32. Tateno T, Asa SL, Zheng L, Mayr T, Ullrich A, Ezzat S. The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis. PLoS Genet 2011; 7(12):e1002400.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  33. Asa SL, Ezzat S. The pathogenesis of pituitary tumours. Nat Rev Cancer 2002; 2(11):836–849.

    Article  PubMed  CAS  Google Scholar 

  34. Chandrasekharappa SC, Guru SC, Manickam P et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997; 276:404–407.

    Article  PubMed  CAS  Google Scholar 

  35. Pellegata NS, Quintanilla-Martinez L, Siggelkow H et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci U S A 2006; 103(42):15558–15563.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  36. Georgitsi M, Raitila A, Karhu A et al. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 2007; 92(8):3321–3325.

    Article  PubMed  CAS  Google Scholar 

  37. Agarwal SK, Mateo CM, Marx SJ. Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. J Clin Endocrinol Metab 2009; 94(5):1826–1834.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  38. Vierimaa O, Georgitsi M, Lehtonen R et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 2006; 312(5777):1228–1230.

    Article  PubMed  CAS  Google Scholar 

  39. Beckers A, Daly AF. The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 2007; 157(4):371–382.

    Article  PubMed  CAS  Google Scholar 

  40. Georgitsi M, De Menis E, Cannavo S et al. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. Clin Endocrinol (Oxf) 2008; 69(4):621–627.

    Article  CAS  Google Scholar 

  41. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985; 64(4):270–283.

    Article  CAS  Google Scholar 

  42. Kirschner LS, Carney JA, Pack SD et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000; 26(1):89–92.

    Article  PubMed  CAS  Google Scholar 

  43. Zhuang Z, Ezzat S, Vortmeyer AO et al. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res 1997; 57:5446–5451.

    PubMed  CAS  Google Scholar 

  44. Asa SL, Somers K, Ezzat S. The MEN-1 gene is rarely down-regulated in pituitary adenomas. J Clin Endocrinol Metab 1998; 83:3210–3212.

    PubMed  CAS  Google Scholar 

  45. Pesatori AC, Baccarelli A, Consonni D et al. Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident. Eur J Endocrinol 2008; 159(6):699–703.

    Article  PubMed  CAS  Google Scholar 

  46. DiGiovanni R, Serra S, Ezzat S, Asa SL. AIP mutations are not identified in patients with sporadic pituitary adenomas. Endocr Pathol 2007; 18(2):76–78.

    Article  PubMed  CAS  Google Scholar 

  47. Kaltsas GA, Kola B, Borboli N et al. Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours. Clin Endocrinol (Oxf) 2002; 57(4):443–448.

    Article  CAS  Google Scholar 

  48. Sandrini F, Kirschner LS, Bei T et al. PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex. J Med Genet 2002; 39(12):e78.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  49. Vallar L, Spada A, Giannattasio G. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 1987; 330:566–568.

    Article  PubMed  CAS  Google Scholar 

  50. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. GTPase inhibiting mutations activate the alpha-chain of Gs ans stimulate adenylate cyclase in human pituitary tumors. Nature 1989; 340:692–696.

    Article  PubMed  CAS  Google Scholar 

  51. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991; 325:1688–1695.

    Article  PubMed  CAS  Google Scholar 

  52. Kovacs K, Horvath E, Thorner MO, Rogol AD. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. Virchows Arch [A] 1984; 403:77–86.

    Article  CAS  Google Scholar 

  53. Hayward BE, Barlier A, Korbonits M et al. Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 2001; 107(6):R31-R36.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  54. Spada A, Arosio M, Bochicchio D et al. Clinical, biochemical and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab 1990; 71:1421–1426.

    Article  PubMed  CAS  Google Scholar 

  55. Asa SL, DiGiovanni R, Jiang J et al. A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors. Cancer Res 2007; 67(15):7505–7511.

    Article  PubMed  CAS  Google Scholar 

  56. Ezzat S, Kontogeorgos G, Redelmeier DA, Horvath E, Harris AG, Kovacs K. In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide. European Journal of Endocrinology 1995; 133:686–690.

    Article  PubMed  CAS  Google Scholar 

  57. Bhayana S, Booth GL, Asa SL, Kovacs K, Ezzat S. The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. J Clin Endocrinol Metab 2005; 90(11):6290–6295.

    Article  PubMed  CAS  Google Scholar 

  58. Asa SL, Ezzat S. The pathogenesis of pituitary tumors. Annu Rev Pathol 2009; 4:97–126.

    Article  PubMed  CAS  Google Scholar 

  59. McCormack AI, McDonald KL, Gill AJ et al. Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours. Clin Endocrinol (Oxf) 2009; 71(2):226–233.

    Article  CAS  Google Scholar 

  60. Fadul CE, Kominsky AL, Meyer LP et al. Long-term response of pituitary carcinoma to temozolomide. Report of two cases. J Neurosurg 2006; 105(4):621–626.

    Article  PubMed  Google Scholar 

  61. Hagen C, Schroeder HD, Hansen S, Hagen C, Andersen M. Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy. Eur J Endocrinol 2009; 161(4):631–637.

    Article  PubMed  CAS  Google Scholar 

  62. Zhu X, Mao X, Hurren R, Schimmer AD, Ezzat S, Asa SL. Deoxyribonucleic acid methyltransferase 3B promotes epigenetic silencing through histone 3 chromatin modifications in pituitary cells. J Clin Endocrinol Metab 2008; 93(9):3610–3617.

    Article  PubMed  CAS  Google Scholar 

  63. Goudie RB, Pinkerton PH. Anterior hypophysitis and Hashimoto’s disease in a young woman. J Pathol Bacteriol 1962; 83:584–585.

    Article  PubMed  CAS  Google Scholar 

  64. Asa SL, Bilbao JM, Kovacs K, Josse RG, Kreines K. Lymphocytic hypophysitis of pregnancy resulting in hypopituitarism: a distinct clinicopathologic entity. Ann Intern Med 1981; 95:166–171.

    Article  PubMed  CAS  Google Scholar 

  65. Crock PA. Cytosolic autoantigens in lymphocytic hypophysitis. J Clin Endocrinol Metab 1998; 83:609–618.

    PubMed  CAS  Google Scholar 

  66. Crock P, Salvi M, Miller A, Wall J, Guyda H. Detection of anti-pituitary autoantibodies by immunoblotting. J Immunol Methods 1993; 162:31–40.

    Article  PubMed  CAS  Google Scholar 

  67. Manetti L, Lupi I, Morselli LL et al. Prevalence and functional significance of antipituitary antibodies in patients with autoimmune and non-autoimmune thyroid diseases. J Clin Endocrinol Metab 2007; 92(6):2176–2181.

    Article  PubMed  CAS  Google Scholar 

  68. O’Dwyer DT, Smith AI, Matthew ML et al. Identification of the 49-kDa autoantigen associated with lymphocytic hypophysitis as alpha-enolase. J Clin Endocrinol Metab 2002; 87(2):752–757.

    PubMed  Google Scholar 

  69. O’Dwyer DT, Clifton V, Hall A, Smith R, Robinson PJ, Crock PA. Pituitary Autoantibodies in Lymphocytic Hypophysitis Target Both gamma- and alpha-Enolase - A Link with Pregnancy? Arch Physiol Biochem 2002; 110(1–2):94–98.

    Article  PubMed  Google Scholar 

  70. Peterson P, Peltonen L. Autoimmune polyendocrinopathy syndrome type 1 (APS1) and AIRE gene: new views on molecular basis of autoimmunity. J Autoimmun 2005; 25 Suppl:49–55.

    Article  PubMed  CAS  Google Scholar 

  71. Bensing S, Fetissov SO, Mulder J et al. Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1. Proc Natl Acad Sci U S A 2007; 104(3):949–954.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  72. Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P. IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 2011; 96(7):1971–1980.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  73. Deshpande V, Zen Y, Chan JK et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012; 25(9):1181–1192.

    Article  PubMed  Google Scholar 

  74. Lammert A, Schneider HJ, Bergmann T et al. Hypophysitis Caused by Ipilimumab in Cancer Patients: Hormone Replacement or Immunosuppressive Therapy. Exp Clin Endocrinol Diabetes 2013.

  75. DeLellis RA, Lloyd RV, Heitz PU, Eng C. Pathology and Genetics of Tumours of Endocrine Organs. Lyons, France: IARC Press, 2004.

    Google Scholar 

  76. Mete O, Asa SL. Clinicopathological correlations in pituitary adenomas. Brain Pathol 2012; 22(4):443–453.

    Article  PubMed  Google Scholar 

  77. Mete O, Asa SL. Therapeutic implications of accurate classification of pituitary adenomas. Semin Diagn Pathol 2013; 30(3):158–164.

    Article  PubMed  Google Scholar 

  78. Asa SL. Tumors of the Pituitary Gland. AFIP Atlas of Tumor Pathology. Series 4, Fascicle 15. Silver Spring, MD, ARP Press, 2011.

  79. Mete O, Ezzat S, Asa SL. Biomarkers of aggressive pituitary adenomas. J Mol Endocrinol 2012; 49(2):R69-R78.

    Article  PubMed  CAS  Google Scholar 

  80. Nose V, Ezzat S, Horvath E et al. Protocol for the examination of specimens from patients with primary pituitary tumors. Arch Pathol Lab Med 2011; 135(5):640–646.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Laboratory Medicine Program, University Health Network, 200 Elizabeth Street, 11th floor, Toronto, Ontario, Canada, M5G 2C4

    Sylvia L. Asa & Ozgur Mete

  2. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada

    Sylvia L. Asa & Ozgur Mete

Authors
  1. Sylvia L. Asa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ozgur Mete
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sylvia L. Asa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Asa, S.L., Mete, O. A History of Pituitary Pathology. Endocr Pathol 25, 6–11 (2014). https://doi.org/10.1007/s12022-013-9284-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-013-9284-5

Keywords

Search

Navigation